MSB 7.69% $1.19 mesoblast limited

Regenerative Medicine and Cell Therapies Virtual Event, page-30

  1. 3,999 Posts.
    lightbulb Created with Sketch. 315
    thanks for your post. I feel these videos, especially the manufacturing ones you’ve made a transcript of have been lost in the intentional noise! Very impressive capacity numbers. It makes you wonder what capabilities are available with more time and transition to 3D. I’m looking forward to MSB informing us of their plans if/when successful. I suspect MSB have spent the last CR on expanding the master cell bank and getting consumables like media ordered while Lonza is sorting plants. I look forward to finally hearing the actual capacity and plans. I suggest he could not state other capacities or talk in anyway of movement to 3D In a fire gone conclusion way as that wouldn’t be pleasing to the FDA. I think roster bio, while having a good crack, they are small fry compared to Lonza. No disrespect intended. The video give me greater confidence in manufacturing, in contrast to the noise that claimed we couldn’t manufacture at scale lol. Seems even roster bio can. I also recal him saying 10 years ago he was involved in a unnamed company which 10 years ago had scale sorted. I wonder who it was.....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.